Phenomic AI

Cell based phenotypic screening has proven to be a promising approach to early drug discovery, however it’s adoption by pharmaceutical research teams has been hindered by challenging assay development and complex data analysis workflows. At Phenomic AI, we’re taking an AI based approach to develop a ground-breaking phenotypic drug discovery platform that accelerates assay development and automates the interpretation of high-content image based screening data. To date we’ve worked with several early adopters of our platform and have setup an internal drug discovery program.